Financial incentives for patients in the treatment of psychosis
Author:
- 30 March 2009
- journal article
- research article
- Published by BMJ in Journal of Medical Ethics
- Vol. 35 (4) , 224-228
Abstract
Poor medication adherence in patients with a psychosis is associated with relapse. It has been proposed that outcomes might be improved by using financial incentives for treatment adherence (FITA). However, a strong moral intuition against this practice has been found. This paper examines the ethics of FITA.Three arguments are presented, which if accepted would severely restrict or even prohibit the practice. These are based on (1) “incommensurable values”, where FITA denigrates an aspect of “respect for the person”, (2) “exploitation”, where unfair advantage is taken of the patient, and (3) “fairness”, where it is difficult to draw a line between those who should and should not be offered payment. A number of practical impediments are also considered.Keywords
This publication has 13 references indexed in Scilit:
- Treatment pressures, leverage, coercion, and compulsion in mental health careJournal of Mental Health, 2008
- Is it acceptable for people to be paid to adhere to medication? NoBMJ, 2007
- Is it acceptable for people to be paid to adhere to medication? YesBMJ, 2007
- What's Wrong with Exploitation?Journal of Applied Philosophy, 2007
- Financial incentives for antipsychotic depot medication: ethical issues: Table 1Journal of Medical Ethics, 2007
- Money for medication: financial incentives to improve medication adherence in assertive outreachPsychiatric Bulletin, 2007
- Adult mental health care in EnglandEuropean Archives of Psychiatry and Clinical Neuroscience, 2007
- Contingency Management for Treatment of Substance AbuseAnnual Review of Clinical Psychology, 2006
- The Nature of CoercionThe Journal of Value Inquiry, 2000
- Should we pay the patient? Review of financial incentives to enhance patient complianceBMJ, 1997